Posted by: admin on: June 4, 2011
Proton pump inhibitors (PPIs) is associated with a dose-dependent loss of protection against hip fracture with alendronate in elderly patients Team@CMHF
Posted by: admin on: May 27, 2011
February 14, 2011 – According to online results of an observational study reported in the Archives of Internal Medicine, “Concurrent use of proton pump inhibitors (PPIs) is associated with a dose-dependent loss of protection against hip fracture with alendronate in elderly patients.”
Posted by: admin on: May 16, 2011
Australian clinical researchers have noted an extraordinary and unexpected benefit of osteoporosis treatment – that people taking bisphosphonates are not only surviving well, better than people without osteoporosis, they appear to be gaining an extra 5 years of life.